New England Asset Management Inc. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,200 shares of the medical research company’s stock after buying an additional 600 shares during the period. New […]
Visionary Wealth Advisors decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,758 shares of the medical research company’s stock after selling 263 shares during the quarter. Visionary Wealth […]
Left Brain Wealth Management LLC boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,013 shares of the medical research company’s stock after purchasing an additional 39 shares during the period. […]
Caxton Associates LP lifted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 282.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,279 shares of the medical research company’s stock after purchasing an additional 9,804 shares during […]
Washington Trust Bank trimmed its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.2% during the fourth quarter, HoldingsChannel reports. The fund owned 3,094 shares of the medical research company’s stock after selling 69 shares during the quarter. Washington Trust Bank’s holdings in Amgen were worth $891,000 at the end of the […]